Capital Research Global Investors Guardant Health, Inc. Transaction History

Capital Research Global Investors

$463 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$25.8 - $39.97 $15.8 Million - $24.4 Million	611,191 Added 36.16%	2,301,472 $68.2 Million
Q2 2023 Aug 11, 2023	BUY	$20.94 - $38.01 $14.5 Million - $26.2 Million	690,281 Added 69.03%	1,690,281 $60.5 Million
Q1 2023 May 15, 2023	SELL	$22.92 - $33.76 $23 Million - $33.8 Million	-1,001,782 Reduced 50.04%	1,000,000 $23.4 Million
Q4 2022 Feb 14, 2023	SELL	$25.44 - $59.78 $3.78 Million - $8.89 Million	-148,722 Reduced 6.92%	2,001,782 $54.4 Million
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $51,125 - $71,431	1,171 Added 0.05%	2,150,504 $116 Million
Q2 2022 Aug 15, 2022	SELL	$28.82 - $77.35 $53.6 Million - $144 Million	-1,860,172 Reduced 46.39%	2,149,333 $86.7 Million
Q1 2022 May 16, 2022	SELL	$48.25 - $100.49 $189 Million - $394 Million	-3,918,197 Reduced 49.42%	4,009,505 $266 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $234 Million - $318 Million	2,640,910 Added 49.95%	7,927,702 $793 Million
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $309 Million - $413 Million	3,128,063 Added 144.9%	5,286,792 $661 Million
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $13.3 Million - $20 Million	120,975 Added 5.94%	2,158,729 $268 Million
Q1 2021 May 14, 2021	BUY	$127.04 - $179.1 $634,056 - $893,888	4,991 Added 0.25%	2,037,754 $311 Million
Q4 2020 Feb 12, 2021	BUY	$99.96 - $135.93 $4.01 Million - $5.45 Million	40,093 Added 2.01%	2,032,763 $262 Million
Q3 2020 Nov 13, 2020	BUY	$80.32 - $111.8 $3.18 Million - $4.43 Million	39,650 Added 2.03%	1,992,670 $223 Million
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $48.4 Million - $78.1 Million	800,887 Added 69.51%	1,953,020 $158 Million
Q1 2020 May 15, 2020	BUY	$59.04 - $88.81 $1.71 Million - $2.57 Million	28,921 Added 2.57%	1,152,133 $80.2 Million
Q4 2019 Feb 18, 2020	BUY	$59.49 - $82.78 $2.62 Million - $3.65 Million	44,061 Added 4.08%	1,123,212 $87.8 Million
Q3 2019 Nov 14, 2019	BUY	$62.59 - $110.3 $28.7 Million - $50.6 Million	458,852 Added 73.97%	1,079,151 $68.9 Million
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $39.7 Million - $56.5 Million	620,299 New	620,299 $53.6 Million

Others Institutions Holding GH

# of Institutions

324

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

Vanguard Group Inc Valley Forge, PA

11.7M
Shares

$552 Million
0.0% of portfolio
Black Rock Inc. New York, NY

11.2M
Shares

$531 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.1M
Shares

$478 Million
0.04% of portfolio
Cadian Capital Management, LP New York, NY

6.93M
Shares

$327 Million
8.13% of portfolio
Deep Track Capital, LP Greenwich, CT

6M
Shares

$283 Million
5.07% of portfolio

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.83B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Account